Status:
UNKNOWN
Percutaneous Cryoablation Versus Partial Nephrectomy for T1b Renal Tumor
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Renal Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of our study is to assess the long-term oncological and functional outcomes of cryoablation for T1b renal tumors, as well as such important parameters as the patient's quality of life after tr...
Eligibility Criteria
Inclusion
- •CT-confirmed renal mass \> 4 to 7 cm (T1b)
Exclusion
- Multiple renal tumors;
- Recurrence of renal tumor;
- Intolerance to iodine-containing contrast agents;
- Pregnancy;
- Patients with Bosniak 4 cysts
- Presence of other oncological diseases;
- Impossibility of organ-preserving treatment due to the proximity of the tumor to the vessels or the calyx-pelvic system
- Absence of malignant pathology based on prior biopsy.
Key Trial Info
Start Date :
May 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 22 2025
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT04506671
Start Date
May 22 2020
End Date
June 22 2025
Last Update
July 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Urology and Reproductive Health, Sechenov University.
Moscow, Russia, 119991